Phenomic AI

About:

Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.

Website: https://phenomic.ai/

Twitter/X: PhenomicAI

Top Investors: Garage Capital, Creative Destruction Lab (CDL), Radical Ventures, Inovia Capital, Cantos

Description:

Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.The company's platform uses artificial intelligence to analyze phenotypes in complex disease models including high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs in an easier way.

Total Funding Amount:

$11.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)phenomic.ai

Founders:

Oren Kraus, Sam Cooper

Number of Employees:

11-50

Last Funding Date:

2020-10-07

IPO Status:

Private

© 2024 MyAiNote.com